Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -10.0% | -30.1% | 0 / 3 | -4.2% | -5.85 pp | -0.82 pp | +27.7% | 0.67 | 4.32 | 220 | −4,2% | 29,1 | −9,9% | 4.32 | 4.99 | −13,4% |
| Pts | 0 | 0 | 0 | 0 | 0 | 4 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 37.500 (close price on 2026-10-14)EPS (TTM): 8.673
Financial charts
1.Revenue & growth
VND bn220Q2/26
1.Revenue & growth
VND bn220Q2/26
2.Profit & growth
VND bn29,1Q2/26
3.Profit mix (Penman)
VND bn166Q2/26
4.Margins & cost structure
%23.3%Q2/26
5.Returns & cash cycle
% · days21.8%Q2/26
6.Earnings quality & cash
VND bn30,1Q2/26
7.Asset structure
VND bn1.092Q2/26
8.Funding & debt health
VND bn · times1.092Q2/26
9.Revenue backlog
VND bn2,25Q2/26
10.Valuation
times · %4,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.729Q2/26
Adjusted EPS growth, latest quarter
-10.0%
Average adjusted EPS growth, 3 quarters
-30.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26